Work

Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918

Year: 2024

Type: erratum

Abstract: In the original publication, there was a mistake in Figure 4B as published [...].

Source: Cancers

DOI: 10.3390/cancers16051026

Authors: Yanyuan Wu, Marianna Sarkissyan, Ochanya Ogah, Juri Kim, Jaydutt V. Vadgama

Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Charles R. Drew University of Medicine and Science

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,296

Funders: National Cancer Institute, National Institute on Minority Health and Health Disparities

Awards: Sustaining Faculty Development & Community Engagement, G8332820752, Center for Accelerating Excellence in Translational Science (AXIS)

OpenAlex ID: W4392366536

Cites: 1

Cited by: 1

Related to: 10